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Abstract
Background: To determine the relationships between regional white matter
lesions (WMLs), lifestyle factors, and cognitive, motor function and mood.
Methods: A comprehensive evaluation, including brain MRI, blood tests, the
Unified Parkinson’s Disease Rating Scale, the Mini Mental State Examination,
and the Geriatric Depression Scale, was performed for people aged 65 years or
older living in Ama-cho on October 1, 2009. Participants were classified by
severity of periventricular hyperintensities (PVH) and deep white matter hyper-
intensities (DWMH) using the Fazekas score. Results: Of 900 eligible partici-
pants, 688 (76.4%) were enrolled, including 303 men. Significant predictors of
severe PVH were older age, lower low-density lipoprotein cholesterol (LDL-C)
levels, elevated blood pressure (BP), cerebral infarction, and no current alcohol
use. Significant predictors of severe DWMH were older age, lower 1,5-anhy-
droglucitol (1,5-AG) levels, elevated BP, cerebral infarction, and no current
alcohol use. Higher cognitive function was associated with younger age, female
sex, mild DWMH, more years of education, and higher high-density lipoprotein
cholesterol levels. Depressive symptoms were associated with lower 1,5-AG lev-
els, lower LDL-C levels, moderate to severe PVH, and no current alcohol use.
Conclusions: White matter lesions in elderly people were related to hyperten-
sion and impaired glucose tolerance. The severity of WMLs was associated with
cognitive function and mood.
Introduction
Large increases in the number of elderly people with cere-
brovascular disorders and dementia in Japan have created
significant economic and personal burdens. Dementias,
such as Alzheimer’s disease and vascular dementia, are the
main causes of functional decline in the elderly, and cere-
brovascular disorder is a major source of bedridden state
(Yoshida et al. 2012). Prevention of these disorders is
important for elderly people to maintain their ability to
perform activities of daily living and a good quality of life.
Cerebral white matter lesions (WMLs) are associated
with declines in cognitive, motor function, and mood
(Gouw et al. 2006; Herrmann et al. 2008; Debette and
Markus 2010). Risk factors for WMLs include lifestyle
factors, hypertension, and renal damage (de Leeuw et al.
2002; Weiner et al. 2009). On the one hand, unlike Wes-
tern countries, Japan has a relatively higher incidence and
mortality caused by stroke than coronary heart disease. In
addition, the dominant type of ischemic stroke in Japan
differs from it in Western countries (Ueshima et al.
2008). In such the situation, we take an interest in
research findings of WMLs in our country. However,
there have been few epidemiological studies of these asso-
ciations in Japan. Therefore, we examined the relationship
between these risk factors and WMLs in Japanese elderly
inhabitants in a rural island town, with very little popula-
tion movement in the elderly.
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Methods
Study Population
This study was conducted in the municipality of Ama-
cho in the northwestern part of Japan (Wada-Isoe et al.
2012). The target population included all persons ages
65 years and older who had been recorded in the Basic
Resident Registration of the Ama-cho on October 1,
2009. The subjects knew the recruitment of this study by
the appeal of Tottori University and the town office. An
exclusion criterion was the usual contraindications to
MRI. The study was approved by the Tottori University
committee for medical research ethics following the prin-
ciples outlined in the Declaration of Helsinki, and all par-
ticipants provided written informed consent.
Data Collection
Hypertension, impaired glucose tolerance, hyperlipidemia,
current smoking and alcohol use, and years of education
were obtained from a patient-administered questionnaire
and review of electronic databases of healthcare system.
Blood pressure (BP) at evaluation was assessed during
medical examinations. Concurrently with the MRI investi-
gation, triglycerides, high-density lipoprotein cholesterol
(HDL-C), low-density lipoprotein cholesterol (LDL-C),
creatinine (Cr), and 1,5-anhydroglucitol (1,5-AG) were
measured by us for this investigation.
MRI and Measurement of WMLs
Brain MRI scans were performed between March 2010 and
May 2010 using 1.5-T scanners (Gyroscan Intera; Philips
Electronics Japan, Tokyo, Japan). The scanning protocol
included a series of axial proton-density (repetition time
[TR], 3000 msec; echo time [TE], 12 msec), T2-weighted
(TR, 3000 msec; TE, 96 msec), and sagittal contiguous T1-
weighted (TR, 8.6 msec; TE, 4 msec) images.
The Fazecas scale was used to assess periventricular hy-
perintensities (PVH) and deep white matter hyperintensi-
ties (DWMH) (Fazekas et al. 1987). Participants were
classified into three severity groups according to their
Fazekas score: mild (0–1), moderate (2), and severe (3).
The presence of infarcts was assessed visually by a neurol-
ogist using a standardized assessment. WMLs were areas
of bright, high-signal intensities noted on MRI T2, and
proton-density-weighted images. Cerebral infarcts were
defined as focal hyperintensities on T2-weighted images
≥3 mm, with corresponding prominent hypointensities
on T1-weighted images.
The two neurologists (M.Y. and M.Y.) evaluated 10%
of cases for degree of concordance. The inter- and intrar-
ater kappa coefficients for PVH were 0.846 and 0.818,
respectively, and for DWMH were 0.660 and 0.867,
respectively.
Assessment of Cognitive, Motor Function,
and Mood
A standardized neurological examination was conducted
by neurologists as previously described, which included an
abbreviated (10-item) version of the motor portion of the
Unified Parkinson’s Disease Rating Scale (mUPDRS)
(Uemura et al. 2011, 2013). The 10 items (each rated from
0 to 4) assessed speech, facial expression, tremor at rest,
rigidity (rated separately in the neck, right arm, left arm,
right leg, and left leg), posture, and body (axial) bradykine-
sia. As mUPDRS is associated with measures of physical
activity obtained using actigraphy, mUPDRS provided a
means to assess motor impairment (Uemura et al. 2011).
The mini mental state examination (MMSE) was adminis-
tered to determine global cognitive function (Wada-Isoe
et al. 2012). The Japanese version of the Geriatric Depres-
sion Scale (GDS) with 15 questions was administered to
assess depressive symptoms (Uemura et al. 2011, 2013).
Statistical Analysis
The chi-square tests were used to determine significant
differences of the frequencies of categories between the
groups. Kruskal–Wallis and Mann-Whitney U tests were
used for demographic and clinical comparisons between
the groups. Multivariate logistic regressions with stepwise
selection and likelihood ratio test were performed to
determine the independent predictors of severe PVH and
DWMH. In multivariate regression analyses, forward step-
wise regression was used to determine the independent
predictors of mUPDRS, MMSE and GDS. We chose vari-
ables with a P value of less than 0.25 in the univariate
analysis as the final candidate variables for the multivari-
ate statistics. We confirmed that predictors were not
highly correlated with others. Significance was defined as
P < 0.05. All analyses were conducted using SPSS (release
20; SPSS, Tokyo, Japan).
Results
Of 900 eligible individuals, 689 (76.6%) were enrolled in
the study. The remaining 211 participants did not undergo
an MRI scan of the brain despite our eager and repeated
appeals prompting their participation. One participant was
excluded from analyses because of poor quality MRI due to
movement. Thus, this study comprises the remaining 688
participants (76.4%). Compared with participants, nonpar-
ticipants were similar in gender, but age of nonparticipants
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was significantly increased compared with participants
(data not shown). The sample included 303 (44%) males.
The sample had a mean  SD age of 76.5  7.1 (age com-
position of participants: 69 years of age or younger, 19.6%;
70–79 years of age, 47.2%; 80–89 years of age, 28.9%;
90 years of age or older, 4.2%). The median score of PVH
and DWMH were 1 (interquartile range, 1–2) and 1 (inter-
quartile range, 1–2), respectively. There were no significant
differences in these variables by sex. Cerebral infarctions
were present in 211 participants (30.7%). Most of cerebral
infarctions were regarded as small infarctions with a diam-
eter of <15 mm.
Predictors of PVH Severity
Table 1 summarizes participant characteristics by PVH
severity. The logistic regression model included age, sys-
tolic blood pressure (SBP), Cr, HDL-C, LDL-C, 1,5-AG,
current drinker, and cerebral infarction. We revealed that
older age, lower LDL-C levels, elevated SBP, presence of
cerebral infarction, and no current alcohol use were sig-
nificant predictors of severe PVH (Table 2).
Predictors of DWMH Severity
Table 3 summarizes participant characteristics by DWMH
severity. The logistic regression model included age, SBP,
Cr, HDL-C, LDL-C, 1,5-AG, current drinker, and cerebral
infarction. We revealed that older age, lower 1,5-AG, ele-
vated SBP, presence of cerebral infarction, and lack of
current alcohol use were significant independent predic-
tors of severe DWMH (Table 4).
Predictors of Motor Function
A total of 581 in 688 MRI recorded participants (250
men) were evaluated for motor function by mUPDRS
(mean  SD, 1.0  1.9). There were no significant gen-
der differences. The mUPDRS score was not a significant
predictor of severe PVH or DWMH in the multiple
regression analyses (data not shown).
Predictors of Cognitive Function
A total of 660 in 688 MRI recorded participants (290
men) were evaluated using the MMSE (mean  SD,
25.9  3.8), and women had a significantly higher mean
score than men (men, 25.6  3.9; women, 26.2  3.7;
P = 0.011). Multivariate regression model included PVH,
DWMH, age, sex, Cr, HDL-C, LDL-C, cerebral infarction,
and years of education. Younger age, female sex, mild
DWMH, more years of education, and higher HDL-C lev-
els were significant predictors of better cognitive function
(Table 5).
Table 1. Characteristics of participants by PVH severity.
Characteristic Mild (n = 438) Moderate (n = 176) Severe (n = 74) All (n = 688)
Male (%) 45.2 38.6 50.0 44.0
Age, mean  SD, years 74.4  6.3 79.5  6.61 82.0  6.91 76.5  7.1
SBP, mean  SD, mmHg 133.3  17.5 136.6  18.6 139.9  19.31 134.7  18.1
DBP, mean  SD, mmHg 74.8  10.3 75.2  10.9 75.8  9.8 75.0  10.4
Cr, mean  SD, mg/dL 0.72  0.22 0.77  0.35 0.87  0.421 0.75  0.29
HDL-C, mean  SD, mg/dL 57.0  14.1 55.1  13.8 53.2  13.11 56.1  14.0
TG, mean  SD, mg/dL 155.6  107.2 147.3  92.9 130.1  78.01 150.7  101.1
LDL-C, mean  SD, mg/dL 101.3  28.5 98.9  28.5 88.8  29.91 99.3  28.9
1,5-AG, mean  SD, lg/mL 21.1  8.8 19.3  9.7 19.1  10.0 20.4  9.2
Cerebral infarction (%) 21.7 44.32 51.42 30.7
Hypertension (%) 60.2 70.52 71.6 64.0
Impaired glucose tolerance (%) 32.9 38.1 36.5 34.6
Hyperlipidemia (%) 34.3 33.0 29.7 33.5
Current smoker (%) 8.0 8.1 10.0 8.3
Current drinker (%) 33.4 24.42 22.9 30.1
mUPDRS, mean  SD 0.8  1.9 1.3  1.91 1.5  1.81 1.0  1.9
MMSE, mean  SD 26.6  3.2 25.3  3.81 23.4  5.41 25.9  3.8
GDS, mean  SD 2.9  2.9 3.8  3.41 4.1  3.7 3.3  3.2
Education, mean  SD, years 9.8  2.1 9.6  2.2 9.1  2.5 9.7  2.2
Cr, creatinine; DBP, diastolic blood pressure; GDS, Geriatric Depression Scale; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipo-
protein cholesterol; mUPDRS, motor component of Unified Parkinson’s Disease Rating Scale; MMSE, mini mental state examination; PVH, periven-
tricular hyperintensities; SBP, systolic blood pressure; SD, standard deviation; TG, triglycerides; 1,5-AG, 1,5-anhydroglucitol.
1P < 0.05, Kruskal–Wallis test with post hoc test versus mild.
2P < 0.05, chi-square test versus mild.
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Predictors of Depressive Symptoms
A total of 631 in 688 MRI recorded participants (278
men) were evaluated using the GDS. The mean  SD
score for all participants was 3.3  3.2, and there were
no significant gender differences. Multivariate regression
model included PVH, DWMH, age, sex, LDL-C, 1,5-
AG, current smoker and drinker, and years of
education. Lower 1,5-AG, lower LDL-C levels,
moderate to severe PVH, and no current alcohol use
were significant predictors of depressive symptoms
(Table 6).
Discussion
In this population-based study, we investigated the rela-
tionship between WMLs, lifestyle factors, and cognitive
and motor function and mood in Japanese elderly people.
Our study had a high participant rate and included many
very elderly in habitants. Independent predictors of severe
PVH were older age, cerebral infarction, lower LDL-C
levels, elevated BP, and lack of current alcohol use. Inde-
pendent predictors of severe DWMH were older age,
cerebral infarction, lower 1,5-AG levels, and elevated BP,
lack of current alcohol use. Individuals with higher global
Table 2. Predictors of severe PVH.1
Variable Regression coefficient OR (95% CI) P Predictive accuracy
Intercept 15.600 <0.001 89.7
Age 0.148 1.160 (1.104–1.218) <0.001
Cerebral infarction 1.279 3.595 (1.901–6.797) <0.001
SBP 0.026 1.026 (1.008–1.045) 0.005
LDL-C 0.016 0.984 (0.972–0.995) 0.006
Current drinker 0.931 0.394 (0.175–0.886) 0.024
CI, confidence interval; Cr, creatinine; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; OR, odds ratio; PVH,
periventricular hyperintensities; SBP, systolic blood pressure; 1,5-AG, 1,5-anhydroglucitol.
Model included age, SBP, Cr, HDL-C, LDL-C, 1,5-AG, current drinker, and cerebral infarction.
1Logistic regression model compared severe PVH versus mild PVH (reference group).
Table 3. Characteristics of participants by DWMH severity.
Characteristic Mild (n = 396) Moderate (n = 189) Severe (n = 103)
Male (%) 45.7 42.3 40.8
Age, mean  SD, years 74.5  6.5 78.8  6.71 80.0  7.31
SBP, mean  SD, mmHg 134.0  18.1 133.7  17.2 139.9  19.11
DBP, mean  SD, mmHg 75.0  10.2 74.2  10.8 76.6  10.2
Cr, mean  SD, mg/dL 0.73  0.22 0.77  0.37 0.82  0.331
HDL-C, mean  SD, mg/dL 56.4  13.2 57.2  16.1 53.2  12.41
TG, mean  SD, mg/dL 153.3  103.9 148.7  107.1 144.5  76.4
LDL-C, mean  SD, mg/dL 101.2  29.4 97.1  27.1 96.3  30.0
1,5-AG, mean  SD, lg/mL 21.5  9.0 19.0  9.21 18.8  9.21
Cerebral infarction (%) 22.7 37.02 49.52
Hypertension (%) 58.7 70.42 72.82
Impaired glucose tolerance (%) 33.1 34.9 39.8
Hyperlipidemia (%) 32.9 33.9 35.0
Current smoker (%) 9.9 5.7 6.2
Current drinker (%) 35.7 22.32 21.92
mUPDRS, mean  SD 0.9  2.0 1.1  1.8 1.2  1.61
MMSE, mean  SD 26.7  3.1 25.1  3.91 24.4  5.01
GDS, mean  SD 3.0  3.0 3.5  3.4 3.8  3.4
Education, mean  SD, years 9.8  2.2 9.7  2.3 9.2  2.1
Cr, creatinine; DBP, diastolic blood pressure; DWMH, deep white matter hyperintensities; GDS, Geriatric Depression Scale; HDL-C, high-density
lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; mUPDRS, motor component of Unified Parkinson’s Disease Rating Scale; MMSE,
mini mental state examination; SBP, systolic blood pressure; SD, standard deviation; TG, triglycerides; 1,5-AG, 1,5-anhydroglucitol.
1P < 0.05, Kruskal–Wallis test with post hoc test versus mild.
2P < 0.05, chi-square test versus mild.
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cognitive function were more likely to be younger, female,
and have more years of education, higher HDL-C levels,
and mild DWMH. Lower levels of depressive symptoms
were associated with higher 1,5-AG levels, higher LDL-C
levels, current alcohol use, and mild PVH.
In previous studies, age and hypertension were
reported to be the most common risk factors for WMLs
(Liao et al. 1997; de Leeuw et al. 2002). The risk of cere-
brovascular disease was found to be increased in individ-
uals with higher BP and BP fluctuations of greater
magnitude (Brickman et al. 2010). Some studies have
suggested that white matter hyperintensities are associated
with diabetes (Murray et al. 2005; van Harten et al. 2007)
whereas others found no association (Bogousslavsky et al.
1987). In this study, hypertension and impaired glucose
tolerance were related to DWMH severity. In addition,
hypertension was related to PVH severity. Associations of
PVH and LDL-C levels were in an unanticipated direc-
tion. Hyperlipidemia is a risk factor for vascular disorder
(Tirschwell et al. 2004) and statin treatment has demon-
strated benefits in stroke prevention and prognosis
(Amarenco et al. 2006; Alvarez-Sabin et al. 2007). Consis-
tent with previous findings (Jimenez-Conde et al. 2010;
Ichikawa et al. 2012), data in this study indicated that
Table 4. Predictors of severe DWMH.1
Variable Regression coefficient OR (95% CI) P Predictive accuracy
Intercept 9.685 <0.001 82.7
Age 0.085 1.088 (1.045–1.133) <0.001
Cerebral infarction 1.223 3.396 (1.950–5.915) <0.001
1,5-AG 0.042 0.959 (0.931–0.988) 0.006
Current drinker 0.852 0.427 (0.220–0.826) 0.012
SBP 0.017 1.017 (1.003–1.032) 0.020
CI, confidence interval; Cr, creatinine; DWMH, deep white matter hyperintensities; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density
lipoprotein cholesterol; OR, odds ratio; SBP, systolic blood pressure; 1,5-AG, 1,5-anhydroglucitol.
Model included age, SBP, Cr, HDL-C, LDL-C, 1,5-AG, current drinker, and cerebral infarction.
1Logistic regression model compared severe DWMH versus mild DWMH (reference group).
Table 5. Predictors of MMSE.
Variable Partial regression coefficient (95%CI) P Predictor importance R2
Intercept 38.105 (34.117 to 42.094) <0.001 0.235
Age 0.205 (0.245 to 0.165) <0.001 0.754
DWMH (mild) 0.925 (0.382 to 1.468) 0.001 0.083
Education 0.219 (0.080 to 0.358) 0.002 0.071
Sex (men) 0.739 (1.257 to 0.222) 0.005 0.058
HDL-C 0.021 (0.002 to 0.040) 0.034 0.033
CI, confidence interval; Cr, creatinine; DWMH, deep white matter hyperintensities; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density
lipoprotein cholesterol; MMSE, mini mental state examination; PVH, periventricular hyperintensities.
Model included age, sex, Cr, HDL-C, LDL-C, cerebral infarction, education, PVH, and DWMH.
Table 6. Predictors of GDS.
Variable Partial regression coefficient (95% CI) P Predictor importance R2
Intercept 2.646 (0.609 to 5.901) 0.111 0.043
Current drinker 0.663 (1.209 to 0.118) 0.017 0.257
PVH (mild) 0.601 (1.152 to 0.049) 0.033 0.206
LDL-C 0.009 (0.018 to 0.001) 0.034 0.204
1,5-AG 0.028 (0.055 to 0.001) 0.044 0.183
Age 0.035 (0.003 to 0.073) 0.069 0.149
CI, confidence interval; DWMH, deep white matter hyperintensities; GDS, Geriatric Depression Scale; LDL-C, low-density lipoprotein cholesterol;
PVH, periventricular hyperintensities; 1,5-AG, 1,5-anhydroglucitol.
Model included age, sex, LDL-C, 1,5-AG, current smoker and drinker, education, PVH, and DWMH.
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higher LDL-C levels were associated with lower severity of
WMLs. The mechanisms of the inverse correlation
between LDL-C and PVH are not fully understood, but
cholesterol is thought to play important roles in neuron
repair and remodeling in the central nervous system (Di-
etschy and Turley 2001). Mielke et al. indicated that high
total cholesterol level in late life is associated with a
reduced risk of dementia. Taken together with our result
showing higher cholesterol was associated reduction of
WMLs, high cholesterol might be associated with better
healthy status in late life (Mielke et al. 2005). Moreover,
statin treatment may protect the vessels of the brain and
increase chances of survival while also being associated
with worsening WMLs (Longstreth et al. 2005).
The distinction between PVH and DWMH is of clinical
significance as they have been associated with different
clinical consequences. DWMH might predominantly dis-
rupt the short association fibers, also known as arcuate U
fibers, which connect adjacent cortical areas. PVH proba-
bly affects the long association fibers that connect the
more distant cortical areas (de Groot et al. 2000). In pre-
vious investigations, PVH burden was related to cognitive
function (Debette et al. 2007) and a decline in mental
processing speed (van den Heuvel et al. 2006). In this
study, improved cognitive function was correlated with
mild DWMH but was not related to PVH severity. A pre-
vious study also found a correlation between DWMH and
cognitive function in middle-aged individuals (Soriano-
Raya et al. 2012). Differences in study methods and par-
ticipant races and ages might account for these conflicting
findings. Increasing severity of generalized brain atrophy
and the presence of cerebral infarcts on MRI are associ-
ated with a steeper decline in cognitive function (Prins
et al. 2005). Therefore, further investigation is necessary
to examine the connections between cognitive function
and brain atrophy.
Some authors have found a correlation between depres-
sion and WMLs (Iidaka et al. 1996; Jorm et al. 2005;
Krishnan et al. 2006; Herrmann et al. 2008). WMLs are
caused by cerebrovascular disease and disrupted fiber
tracts within frontostriatal circuits. Because of the
involvement of frontostriatal circuits in the regulation of
mood, disruption of these circuits may lead to a discon-
nection syndrome (Herrmann et al. 2008). WMLs are
believed to be primarily caused by hypoperfusion and
arteriosclerosis (Liao et al. 1997). Decline in total cerebral
blood flow is associated with an increase in the volume of
PVH but not DWMH (ten Dam et al. 2007). PVH may
be affected by longer term vascular disorder. Our finding
of a relationship between depressive symptoms and PVH
supports the vascular hypothesis of depression.
This study has some limitations that should be men-
tioned. The visual rating scale for assessing WMLs used
in this study may differ from quantitative volumetric
methods. However, because significant agreement
between the Fazekas scale and quantitative volumetric
measurement has been shown (Kapeller et al. 2003), the
method used to assess WMLs is not expected to affect
the findings. The cross-sectional nature of this study
precludes conclusions about causality. In addition, this
study did not assess the treatments participants received
over time, which may have affected results. For exam-
ple, a previous study found that individuals who used
antihypertensive medication and had controlled BP had
a reduced risk of severe WMLs (Dufouil et al. 2001; de
Leeuw et al. 2002). Both atrophic and ischemic imaging
changes are driven by altered glycemic and BP control
beginning in midlife (Knopman et al. 2011). We evalu-
ated BP values and clinical biochemistry parameters,
but did not include treatment and response to treat-
ment in our models. Although efforts to study regional
white matter changes have been initiated, future investi-
gations should seek to define longitudinal relationships
between WMLs and other factors.
In conclusion, investigators have begun to take notice
of associations between hypertension, glucose intolerance,
depression, and cognitive decline. Our population-based
study indicated that WMLs in the elderly were related to
hypertension and impaired glucose tolerance, and that the
severity of WMLs was associated with cognitive function
and mood.
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